Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis
NCT00111098
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Disease
Interventions
DRUG:
Darbepoetin Alfa
Sponsor
Amgen